Global Microfluidics Market Overview 2018: Organ/Body-on-a-Chip Based on Microfluidic Technology the Next Big Thing in Drug Discovery?

Dublin, May 28, 2018 (GLOBE NEWSWIRE) — The “Microfluidics – A Global Market Overview” report has been added to’s offering. 

Point of Care (PoC) Diagnostics is projected the fastest growing application area of microfluidics with a CAGR of 19.2% and is also estimated the largest consumer of microfluidics estimated at US$1.6 billion in 2017 and expected to touch US$4.5 billion in 2023.

Microfluidics can be described as the manipulation and analysis of minute volumes of fluid and has evolved over the past three decades into a powerful technology with a number of established and relevant applications within the biological sciences. The research and development conducted over the years in this unique technology has yielded an abundance of techniques that enhance biological assays through the miniaturization of existing methods, in addition to developing innovative analytical approaches. 



  • Abbott Laboratories (United States)
  • Agilent Technologies, Inc. (United States)
  • Bartels Mikrotechnik GmbH (Germany)
  • Becton, Dickinson And Company (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Blacktrace Holdings Ltd. (United Kingdom)
  • Danaher Corporation (United States)
  • Elveflow (France)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Fluidigm Corporation (United States)
  • Hewlett Packard Enterprise Development LP (United States)
  • IDEX Health & Science LLC (United States)
  • Illumina, Inc. (United States)
  • Johnson & Johnson (United States)
  • Microfluidic Chipshop GmbH (Germany)
  • Micronics, Inc. (United States)
  • Micronit Microtechnologies B.V. (The Netherlands)
  • Perkinelmer, Inc. (United States)
  • Qiagen NV (The Netherlands)
  • Shimadzu Corporation (Japan)
  • Siemens Healthcare Gmbh (Germany)
  • Thermo Fisher Scientific Inc. (United States)
  • uFluidix (Canada)


Read More